MDLN - CIK 0002046386
The table below shows Medline Inc.'s cash flow statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Operating cash flow | $1.74B | $1.77B | $1.69B |
| Capital expenditure | $447.00M | $354.00M | $275.00M |
| Investing cash flow | -$474.00M | -$1.49B | -$312.00M |
| Dividends paid | - | - | - |
| Stock buybacks | $33.00M | $20.00M | $0.00 |
| Financing cash flow | $399.00M | -$1.61B | -$191.00M |
Medline Inc. reported operating cash flow of $1.74B for fiscal year 2025. That is down 1.4% from $1.77B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.